Previous Article | Next Article 
Molecular and Cellular Biology, November 2000, p. 8580-8589, Vol. 20, No. 22
0270-7306/00/$04.00+0
Distinct p300-Responsive Mechanisms Promote
Caspase-Dependent Apoptosis by Human T-Cell Lymphotropic Virus
Type 1 Tax Protein
Christophe
Nicot* and
Robert
Harrod
Basic Research Laboratory, Division of Basic
Sciences, National Cancer Institute, National Institutes of Health,
Bethesda, Maryland 20892
Received 2 May 2000/Returned for modification 9 June 2000/Accepted 21 August 2000
 |
ABSTRACT |
The dysregulation of cellular apoptosis pathways has emerged as a
critical early event associated with the development of many types of
human cancers. Numerous viral and cellular oncogenes, aside from their
inherent transforming properties, are known to induce programmed cell
death, consistent with the hypothesis that genetic defects are required
to support tumor survival. Here, we report that nuclear expression of
the CREB-binding protein (CBP)/p300-binding domain of the human T-cell
lymphotropic virus type 1 (HTLV-1) transactivator, Tax, triggers an
apoptotic death-inducing signal during short-term clonal analyses, as
well as in transient cell death assays. Coexpression of the
antiapoptotic factor Bcl-2 increased serum stimulation; incubation with
the chemical caspase inhibitor z-Val-Ala-DL-Asp
fluoromethylketone antagonized Tax-induced cell death. The
CBP/p300-binding defective Tax mutants K88A and V89A exhibited markedly
reduced cytotoxic effects compared to the wild-type Tax protein.
Importantly, nuclear expression of the minimal CBP/p300-binding peptide
of Tax induced apoptosis in the absence of Tax-dependent
transcriptional activities, while its K88A counterpart did not cause
cell death. Further, Tax-mediated apoptosis was effectively prevented
by ectopic expression of the p300 coactivator. We also report that
activation of the NF-
B transcription pathway by Tax, under growth
arrest conditions, results in apoptosis that occurs independent of
direct Tax coactivator effects. Our results allude to a novel pivotal
role for the transcriptional coactivator p300 in determining cell fate
and raise the possibility that dysregulated coactivator usage may pose
an early barrier to transformation that must be selectively overcome as
a prerequisite for the initiation of neoplasia.
 |
INTRODUCTION |
Apoptosis is an active physiological
process that plays an essential role during tissue development and in
the elimination of virus-infected or potentially cancerous cells.
Accumulating evidence indicates that imbalances occurring between
cellular death-inducing and proliferation pathways significantly
contribute to oncogenesis (45, 46, 52). The mechanisms by
which transforming viruses cooperate with cellular factors to promote
neoplasia provide paradigm examples of this phenomenon, as certain
transforming viruses are reported to cause programmed cell death under
various conditions. The human T-cell lymphotropic virus type 1 (HTLV-1) has been linked to the development of adult T-cell leukemia-lymphoma (ATLL) as well as a neurodegenerative disorder known as
HTLV-1-associated myelopathy-tropical spastic paraparesis (HAM/TSP)
(15, 37, 42). The viral transactivator, Tax, is thought to
play an essential role during the initial stages of CD4+
T-cell immortalization by HTLV-1. However, persistent infection of
lymphocytes in vivo is usually correlated with reduced Tax expression.
Of related importance, immortalization of peripheral blood mononuclear
cells by HTLV-1 in vitro is strictly dependent on interleukin-2 (IL-2)
and could reflect IL-2-induced increases in intracellular levels of the
antiapoptotic factors Bcl-2 and Bcl-XL (33). Somatic
mutations are believed to select for IL-2 independence corresponding
with increases in detectable Tax protein. Significantly, numerous
studies have shown that persistent Tax expression is associated with
apoptosis in nonlymphoid and lymphoid-derived cell lines (11, 12,
18, 28, 31, 36, 58). In this respect, Tax resembles other
cellular and viral oncogene products, such as c-Myc, c-Jun, adenovirus
E1A 12S protein, polyomavirus T antigen, and human papillomavirus E7
protein, that possess both transforming and apoptosis-inducing
properties (1, 38, 39, 57). Tax has also been shown to
affect various cell cycle modulators and therefore is similar to
certain regulators of cellular proliferation, including E2F, pRB, p53,
and cyclin D, which are known to function as potent inducers of
cellular death (1, 5, 8, 39, 41).
Several recent reports have demonstrated that HTLV-1 Tax recruits the
transcriptional coactivators CREB-binding protein (CBP) and its
synologue p300, in order to drive constitutive, signal-independent long
terminal repeat (LTR) transactivation (16, 20, 21, 27).
Numerous factors have been shown to interact with CBP/p300 in an often
mutually exclusive manner (13, 17, 24), an observation that
has led to the suggestion that rate-limiting nuclear CBP/p300 may
arbitrate between antagonistic signals (23, 25, 44, 48).
Indeed, perturbation of CBP/p300 functions has been associated with
both excessive cellular death (degenerative disorders) and proliferative diseases (cancer). Heterozygous allelic mutations of CBP
in humans have been linked to the genetic disorder Rubenstein-Taybi syndrome, which is frequently associated with mental retardation and
developmental abnormalities (40). Moreover, homozygous p300 knockout mice were reported to exhibit high degrees of embryonic lethality as well as profound neuronal developmental defects, illustrating the importance of CBP/p300 for the maintenance of cellular
homeostasis (60).
ATLL and HAM/TSP have their etiologies in uncontrolled cellular
proliferation and excessive cell death, respectively. While direct
and/or indirect perturbation of CBP/p300 activities by Tax might
significantly contribute to the concerted dysregulation of growth and
proliferative pathways, it also represents an attractive candidate
mechanism by which Tax expression might induce apoptosis. In this
study, we investigated the molecular mechanisms underlying Tax-mediated
cell death. Our results demonstrate that nuclear expression of the
CBP/p300-binding domain of Tax induces apoptosis in HeLa cells under
growth arrest conditions. The Tax mutants K88A and V89A, defective for
CBP/p300 interactions, exhibited markedly reduced cytotoxic effects
compared to the wild-type Tax protein. Nuclear expression of the
minimal coactivator-binding peptide of Tax caused programmed cell death
in the absence of transactivation. Consistent with these observations,
Tax-mediated apoptosis was efficiently prevented by ectopic expression
of p300. We have also observed that NF-
B transcriptional activation
by Tax results in significant levels of apoptosis, occurring
independent of direct Tax coactivator effects. These findings suggest
that limiting nuclear coactivator concentrations may pose an early barrier to oncogenic transformation which must be selectively overcome
as a prerequisite for the establishment of neoplasia.
 |
MATERIALS AND METHODS |
Cell culture.
HeLa cells obtained from the American Type
Culture Collection were cultured in Dulbecco's modified Eagle's
medium (DMEM; Life Technologies, Inc.), supplemented with 10% fetal
bovine serum (FBS), penicillin (100 U), and streptomycin sulfate (100 µg/ml). HeLa clones that transiently expressed various Tax-derived
mutant proteins were generated by electroporation using a BTX Electro Cell Manipulator (set at 250 V, 800 µF, and 13 ohms). After 2 weeks
of selection in DMEM containing 10% FBS and puromycin (2 µg/ml),
several clones were isolated for each Tax mutant, expanded in
puromycin-free medium, and analyzed.
Plasmids and transfections.
The retrovirus-based and
cytomegalovirus (CMV)-driven wild-type and mutant Tax expression
plasmids, as well as the CMV-p300 expression construct, have been
previously reported (14, 21, 34, 49). Green fluorescent
protein (GFP)-nuclear localization signal (NLS)-Tax peptide fusion
expression vectors NLS-Tax76-95-GFP and
NLS-K88A76-95-GFP were generated by annealing the
oligonucleotides 3'-ACTCACTAACCGCCCCATTCCTGGAACTCCCAGAATCTCCAAGAGAAGGCAAAGAAAAACCCGTA-5' plus
3'-ATACGGGTTTTTCTTTGCCTTCTCTTGGAGATTCTGGGAGTTCCAGGAATGGGGCGGTTAGTGAG-5' (NLS-Tax76-95) and
3'-ACTCACTAACCGCCCCATTCCTGGCGCTCCCAGAATCTCCAAGAGAAGGCAAAGAAAAACCCGTA-5' plus
3'-ATACGGGTTTTTCTTTGCCTTCTCTTGGAGATTCTGGGAGCGCCAGGAATGGGGCGGTTAGTGAG-5' (NLS-K88A76-95), followed by ligation into the
pcDNA3.1/CT-GFP-TOPO cloning plasmid (Invitrogen, Inc.). Clones were
checked for orientation by KpnI/NheI digestion
and visually for expression of GFP in transfected HeLa cells. The
-galactosidase reporter plasmid pCMV.SPORT-
gal was purchased from
Life Technologies. Transient DNA transfections of HeLa cells were
performed using the Lipofectamine reagent (Life Technologies) in
accordance with the manufacturer's instructions. HTLV-1 LTR- and
NF-
B-luciferase reporter plasmids (HTLV-LTR-Luc and NF-
B-Luc,
respectively) as well as the dominant mutant I
B
S32/34A have been
previously reported (32).
Transient apoptosis assays.
Transient cell death assays were
performed as previously reported (7, 29, 30). The Tax
expression vectors to be analyzed were cotransfected with plasmid
pCMV.SPORT-
gal in serum-free medium, using the Lipofectamine
reagent; 6 h posttransfection, the medium was replaced with
DMEM-10% FBS, and reaction mixtures were incubated overnight. On the
following day, the medium was replaced with DMEM-1% FBS, and the
cells were incubated for an additional 48 h. Nonadherent cells
were removed by washing the monolayers three times with
phosphate-buffered saline (PBS). The remaining adherent cells were
fixed with 0.2% glutaraldehyde-1% formaldehyde in PBS for 5 min at
room temperature, washed twice with PBS, and stained with
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal)
reagent as previously described (48). In this assay, the
expression of a death-inducing gene results in a significant decrease
in the observed number of
-galactosidase-expressing cells.
Therefore, the percentages of cytotoxicity reported for Tax-expressing
vectors inversely correlates with the number of
-galactosidase-expressing cells. The percentage of cytotoxicity reported for each construct is derived from the average number of blue
cells counted within 10 visual fields at a magnification of ×400 from
at least three independent experiments.
Flow cytometry.
HeLa vector control (N2)-transfected
(HeLa-N2) and HeLa Tax-expressing (HeLa-Tax) clones were serum starved;
both adherent and non adherent cells were collected by centrifugation,
washed with PBS-10 mM HEPES (pH 7.3), and fixed in 70% ethanol-PBS.
The cells were then washed twice and incubated for 45 min at 37°C in
a propidium iodide solution (69 µM propidium iodide in 38 mM sodium
citrate buffer containing 5 µg of RNase/ml); cellular DNA contents
were determined by fluorescence-activated cell sorting (FACS) analyses
(Beckman-Coulter Epics Elite flow cytometer). Data curves were fitted
using the MODFIT LT software package (Berity Software House, Inc.,
Topsham, Maine) in order to calculate the percentage of cells
containing subgenomic DNA contents reflective of apoptosis.
Oligonucleosomal DNA fragmentation.
HeLa-N2, HeLa-Tax M47,
and HeLa-NLS-
N81 clones were serum starved, and both adherent and
nonadherent cells were collected by centrifugation. Cells were lysed in
Tris (10 mM [pH 8.0])-EDTA (1 mM)-sodium dodecyl sulfate (SDS;
0.5%); RNase (20 µg/ml) was added, and reaction mixtures were
incubated for 1 h at 37°C. Proteinase K (100 µg/ml) was added,
and samples were incubated overnight at 56°C. Proteins were extracted
by phenol-chloroform, and DNA was precipitated overnight at
80°C;
10 µg of DNA from each clone was analyzed in a 2% agarose gel.
Western blot analyses.
Total cellular proteins were
extracted in radioimmunoprecipitation assay buffer (10 mM Tris-HCl [pH
8.0], 150 mM NaCl, 0.5% [vol/vol] NP-40, 0.1% deoxycholate, 1 mM
EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 µg of aprotinin/ml, 2 µg of leupeptin/ml); protein concentrations were determined using the
Bradford microassay. Fifty micrograms of protein for each sample were
resolved through an SDS-12.5% polyacrylamide gel and transferred onto
nitrocellulose membranes (Schleicher & Schuell, Inc.). Nonspecific
sites were blocked by incubation at 4°C for 2 h in PBS
containing 3% (wt/vol) bovine serum albumin and 0.5% (vol/vol) Tween
20. Tax proteins were detected with a rabbit polyclonal antibody
(Tax-C; diluted 1:5,000 in BLOTTO buffer [50 mM Tris-HCl {pH 8.0},
2 mM CaCl2, 80 mM NaCl, 0.2% {vol/vol} NP-40, 0.02%
{wt/vol} sodium azide, 5% {wt/vol} nonfat dry milk]) or with
a monoclonal antibody against Tax (diluted 1:20 in BLOTTO buffer). The
p300 transcriptional coactivator was detected using a rabbit polyclonal
antibody against recombinant human p300 (Santa Cruz Biotechnology,
Inc.). Following incubation with the primary antibodies, the blots were
washed and incubated for 1 h at 4°C with appropriate horseradish
peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology)
and developed using a chemiluminescent substrate (SuperSignal; Pierce,
Inc.).
Coimmunoprecipitations.
HeLa cells were transfected with 2 µg of CMV-wild-type Tax (CMV-Tax) or CMV-mutant Tax expression
construct. Cells were harvested by scraping, washed three times with
PBS, and lysed in radioimmunoprecipitation assay buffer containing 50 ng of each of the protease inhibitors pepstatin, leupeptin,
chymostatin, bestatin, and antipain dihydrochloride (Boehringer
Mannheim Corp.) per ml. Lysates were precleared by incubation with 20 µl of protein G-agarose (Gibco/BRL, Life Technologies, Inc.) and 5 µl of nonspecific antiserum for 30 min at 4°C, followed by
centrifugation at 1,200 rpm for 5 min. Rabbit polyclonal anti-human p300 antibody (7.5 µl; Santa Cruz Biotechnology) was added to each
sample, and binding reaction mixtures were incubated at 4°C for
1 h; 60 µl of protein G-agarose was then added, and the samples were incubated overnight. Immunocomplexes were washed three times with
500 µl of lysis buffer and resuspended in SDS-polyacrylamide gel
electrophoresis loading buffer. Samples were resolved through an
SDS-12.5% polyacrylamide gel and transferred to nitrocellulose membranes; an anti-Tax monoclonal antibody was used to detect wild-type
or mutant Tax proteins immunocomplexed with p300.
Immunofluorescence and confocal microscopy.
HeLa cells
plated on culture slides (Nalge Nunc International) were transfected
with CMV-Tax, CMV-K88A, CMV-V89A, CMV-L90A, or an empty CMV vector as a
control. Alternatively, cells were transfected with a constant
concentration of CMV-Tax or empty vector in the presence of increasing
concentrations of a CMV-driven p300 expression vector. Six hours
posttransfection, the medium was replaced with DMEM-1% FBS and
reaction mixtures were incubated for an additional 24 h. The
serum-starved cells were washed twice with PBS, fixed, and blocked for
1 h at room temperature in 3% (wt/vol) bovine serum
albumin-0.5% (vol/vol) Tween 20 in PBS. Slides were incubated for
2 h with an anti-Tax monoclonal antibody, then incubated for
1 h in rhodamine red-conjugated donkey anti-mouse antibody
(Jackson ImmunoResearch Laboratories, Inc.), and stained with
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI; 2 µg/ml; Molecular Probes, Inc., Eugene, Oreg.). Nuclear fragmentation (pyknosis), characteristic of apoptosis, was easily identifiable by
atypical DAPI-staining nuclei in Tax-expressing cells. The procedure
used for the detection of truncated Tax mutant proteins by
immunofluorescence microscopy has been previously reported (34). GFP and GFP-NLS-Tax peptide fusions were observed, and relative intensities were quantified in transfected HeLa cells under
high-serum (20% FBS) conditions by quantitative confocal microscopy at a magnification of ×4,000 using a Leica TCS
spectrophotometric confocal microscope equipped with krypton and argon
lasers and controlled by a Windows NT-based workstation with Leica TCS
quantitative software.
 |
RESULTS |
Persistent NF-
B activation enhances HTLV-1 Tax-induced apoptotic
effects.
Like other cellular and viral oncogene products, the
HTLV-1 Tax has been shown to induce programmed cell death in various cell types, including fibroblasts and Jurkat lymphocytes, in response to growth arrest signals such as
irradiation, serum deprivation, or
genotoxic agents (11, 12, 18, 28, 31, 36, 58). While
Tax-mediated apoptosis may contribute to neurodegenerative conditions
observed in HAM/TSP patients, the molecular basis underlying Tax
death-inducing effects remains poorly understood. Thus, the apoptotic
potentials of wild-type Tax and mutants M47, M22, and G148V were
analyzed using a transient apoptosis assay referred to elsewhere as the
blue-death assay (Fig. 1A; references
7, 29, and 30). This system is
based on the fact that concomitant expression of a death-inducing gene,
together with a CMV-lacZ reporter gene, will yield a
significant reduction in the number of
-galactosidase-expressing
cells observed as a measure of cell death. Hence, the degree of
cytotoxicity is inversely correlated with the number of
-galactosidase-expressing cells. Consistent with reports by others,
M47 activated the NF-
B transcription pathway but remained defective
for transactivation via CREB/ATF-1 factors (Fig. 1C and D). The M22 and
G148V mutants were still able to transactivate through CREB/ATF-1
signaling but were unable to stimulate NF-
B activation (Fig. 1C and
D). Interestingly, both M47 and wild-type Tax proteins reproducibly
yielded higher cytoxicities compared to mutants M22 and G148V,
suggesting that under cell stress conditions, persistent activation of
NF-
B may cause a further increase in the intrinsic toxicity of the
HTLV-1 transactivator (Fig. 1B). Previous studies have demonstrated
that M47 and G148V differentially interact with the transcriptional coactivators CBP/p300 (4). To assess whether differential
coactivator utilization, as opposed to NF-
B transactivation, was
involved in Tax-mediated cell death, a CMV-driven Tax expression
construct was cotransfected in the presence of increasing
concentrations of I
B
S32/34, a potent inhibitor of NF-
B (Fig.
1F). Surprisingly, Tax-induced cell death was partially inhibited in
the presence of increasing amounts of I
B
S32/34, indicating that
NF-
B transactivation may be involved in promoting Tax-mediated
apoptosis (Fig. 1E). This effect was not due to general alterations in
Tax transcriptional activities, as the ability of Tax to transactivate
the HTLV-1 LTR, in either the absence or presence of I
B
S32/34,
was uncompromised (Fig. 1G). Indeed, the fact that M22 and G148V
mutants retained some degrees of cytotoxicity suggested that in
addition to NF-
B transactivation, other Tax-associated functions are
involved in promoting the apoptotic phenotypes observed.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Schematic diagram of HTLV-1 Tax indicating the
relative positions of point mutations and functional domains. The
N81 and N109 truncations are shown fused to the NLS of the SV40
large T antigen. (B) Cytotoxicity induced by the wild-type Tax (WT) and
Tax mutants was quantified by transient cell death assays in HeLa cells
as described in Materials and Methods. Transactivation phenotypes for
each Tax vector were confirmed by cotransfection of HeLa cells with the
HTLV-LTR-Luc (1 µg) (C) or NF- B-Luc (1 µg) (D) reporter
construct with various Tax expression plasmids (2 µg).
CMV-Renilla (0.1 µg) was added to control for transfection
efficiencies. (E) The empty N2 vector or a wild-type Tax expression
construct was cotransfected together with increasing amounts (0.05, 0.1, and 0.15 µg) of the I B S32/34A plasmid in transient
cytotoxicity assays. Total amounts of transfected DNAs were held
constant by adding the RcCMV vector; CMV-Renilla (0.1 µg)
was added to control for transfection efficiencies. Effects of I B
S32/34A expression on Tax-mediated transactivation was assayed by
cotransfecting HeLa cells with the NF- B-Luc (1 µg) (F) or
HTLV-LTR-Luc (1 µg) (G) reporter plasmid with a wild-type Tax
expression construct (2 µg). Error bars represent standard deviations
between experiments.
|
|
Tax induces apoptosis during short-term clonal analyses in HeLa
cells.
We have previously described several HeLa clones,
expressing the cytoplasmic, Tax-derived truncations
N109 and
N81,
devoid of cytopathic effects (Fig. 1A; reference
34). While a wild-type Tax-expressing HeLa clone
could not be derived, several clones that expressed the mutants M47 and
NLS-
N81 were obtained. Under high-density culture conditions, these
cells exhibited altered morphologies resembling those previously
reported to be associated with apoptosis (Fig.
2A). In the presence of a
growth-arresting signal such as serum deprivation, M47 and
NLS-
N81-expressing HeLa clones displayed a loss of surface adherence
properties and tended to round up and cluster, appearing in a focal
plane separate from that occupied by HeLa-N2 control cells cultured
under identical conditions (Fig. 2A). When the DNA contents of these
clones were analyzed by flow cytometry, both M47- and
NLS-
N81-expressing HeLa clones presented clear sub-G1
peak populations, displaying approximately 80 and 50% apoptotic
fractions, respectively (Fig. 2B). By contrast, the HeLa-N2 cells
exhibited a normal cell cycle progression profile. Prominent
oligonucleosomal DNA fragmentation, a unique feature of apoptotic cell
death, was detected in the M47- and, to a lesser extent,
NLS-
N81-expressing HeLa clones but not in the N2 vector
control-containing cells (Fig. 2C). Expression of the M47 and
NLS-
N81 mutant proteins in HeLa clones was confirmed by Western blot
analysis; the HTLV-1 transformed cell line Hut-102 was included for
comparison (Fig. 2D).

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Morphological changes accompanying the expression of
M47 and NLS- N81 Tax-derived proteins in serum-starved HeLa clones
were visualized by light-field microscopy at an original magnification
of ×400. The HeLa-N2 clone is included for comparison. Representative
phenotypes are shown. (B) FACS analyses of the HeLa-N2 and HeLa-Tax
clones were performed following 72 h of serum deprivation (1%
FBS). The percentage of apoptosis as measured by the sub-G1
peak is indicated for each population. (C) Oligonucleosomal genomic
fragmentation in M47- and NLS- N81-expressing HeLa clones. Ten
micrograms of DNA was extracted as described in Materials and Methods
and resolved on a 2% agarose gel. HeLa-N2 was included as a control.
(D) Expression of the M47 and NLS- N81 mutant proteins in HeLa clones
was detected by immunoblot analysis using a Tax monoclonal antibody.
The HTLV-1-transformed cell line Hut-102 is shown for comparison.
|
|
Nuclear expression of amino acids 81 to 109 of Tax coincides with
apoptosis.
To extend the above-mentioned observations, we next
tested the cytotoxic potentials of various Tax-derived truncation
mutants, expressed either in the cytoplasm or in the nucleus, in
transient cell death assays. Subcellular localizations of the wild-type Tax and mutant proteins were confirmed by immunofluorescence microscopy using a rabbit polyclonal antibody raised against the carboxyl terminus
of Tax (Fig. 3A). Expectedly, a control
plasmid encoding the proapoptotic gene product Bax was highly apoptotic
under conditions used in our assay, resulting in cell death that
exceeded 95% relative to the empty vector control (Fig. 3B). Wild-type
Tax displayed approximately 80% cytotoxicity, whereas the NLS-
N81
construct exhibited reduced (approximately 40%) but significant
apoptosis-inducing activity (Fig. 3B). Because expression of the
NLS-
N109 mutant was not associated with cell death, the apoptotic
effects observed using the NLS-
N81 construct cannot be attributed to
the presence of the simian virus 40 (SV40) large T-antigen-derived NLS.
Consistent with our previous results (34), the NLS-
N81
construct did not lead to significant activation of the NF-
B pathway
(approximately 10% relative to wild-type Tax [unpublished data]); in
addition, this mutant was unable to stimulate transcription through
CREB/ATF-1 and serum response factor (SRF) pathways. In contrast to the
NLS-
N81, its cytoplasmic counterpart,
N81, was not cytotoxic,
suggesting that nuclear expression is essential for the apoptotic
effects of Tax. Further, deletion of amino acid residues 81 to 108 (
N109) (34), while having little effect on
transcriptional activities, resulted in the abrogation of cytotoxicity,
indicative that apoptosis observed concomitant with NLS-
N81
expression occurred independent of transcriptional activation.
Collectively, these results support a role for nuclear expression of
amino acid residues 81 to 108 of Tax in mediating programmed cell
death.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Subcellular localizations of wild-type Tax (WT) and
truncation mutants in transfected HeLa cells were determined by
immunofluorescence microscopy using an anti-Tax rabbit polyclonal
antibody. (B) Cytotoxicity induced by Tax mutants was quantified by
transient cell death assays. A CMV-Bax expression construct was
included as a positive control for apoptosis. Results shown are
representative of four independent transfections; error bars represent
standard deviations.
|
|
Tax-induced cell death requires caspase activation and is prevented
by Bcl-2 expression or serum stimulation.
Previous reports have
demonstrated that Bcl-2 expression blocks both Tax- and HTLV-1-mediated
apoptosis (31, 58). Under the conditions of our transient
cell death assay, Bcl-2 coexpression efficiently inhibited cytotoxicity
resulting from the expression of the wild-type Tax, M47, and NLS-
N81
proteins (Fig. 4A). In agreement with a
recent study which showed that Tax-induced apoptosis could be prevented
by caspase inhibitors in Jurkat lymphocytes (12), a
cell-permeable, peptide analogue inhibitor of the ICE/CED-3-related protease, z-Val-Ala-DL-Asp fluoromethylketone (zVAD-fmk),
inhibited Tax-induced apoptosis in HeLa cells in a
dosage-dependent manner (Fig. 4B).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Tax-induced apoptosis in transient cell death assays
was effectively inhibited by coexpression of the antiapoptotic gene
product Bcl-2. Results are representative of three independent
experiments. Error bars are indicative of standard deviations. WT,
wild-type Tax. (B) Tax-mediated cell death was blocked by treatment
with increasing concentrations of the chemical caspase inhibitor
zVAD-fmk; the empty vector is shown as a control. (C) Apoptosis in the
HeLa-M47 clone following 72 h of serum stimulation (0.5, 5, and
20% FBS) was evaluated by propidium iodide staining and FACS analyses.
(D) Transient cytotoxicity assays were performed using an empty vector
control, CMV-Tax, and CMV-M47 expression constructs under varied serum
concentrations (1 and 20% FBS) as described in Materials and Methods;
error bars are shown.
|
|
Prior observations that increased serum concentrations countered
c-Myc-associated apoptosis (
19) prompted us to investigate
the putative modulatory effects of serum-dependent factors upon
Tax-mediated cell death. Puromycin-selected, N2 vector control-
and
M47-expressing HeLa clones were cultured in media containing
varied
serum concentrations; after 72 h, both adherent and nonadherent
cells were harvested, and their DNA contents were analyzed by
FACS. The
results shown in Fig.
4C indicate that increased serum
stimulation
protected Tax-expressing cells from undergoing apoptosis,
suggesting
that an SRF(s) interferes with the death-effecting
signal induced by
Tax. No alterations in normal cell cycle progression
were observed for
the HeLa-N2 cell line (data not shown). Similar
results were obtained
using both the wild-type Tax and M47 expression
constructs in the
transient cell death assay, excluding the possibility
that
signal-responsive cellular pathways may have been adversely
affected as
a result of the puromycin selection (Fig.
4D).
Tax mutants defective for CBP/p300 interactions exhibit markedly
reduced apoptotic phenotypes.
The CBP/p300-binding domain of the
HTLV-1 Tax has been previously determined to reside between amino acid
residues 76 and 95 (21), a region coinciding with sequences
that are shown here to be associated with the viral transactivator's
apoptotic function. The Tax mutants K88A and V89A contain single amino
acid substitutions and have been characterized as being defective for
interactions with CBP, while another mutant located adjacent to this
region, L90A, exhibited CBP binding and LTR transactivation comparable to that observed for the wild-type Tax (20, 21). In vivo
interactions between these Tax-derived mutants and the p300
transcriptional coactivator were evaluated in transfected HeLa cells.
Consistent with their observed binding to CBP, both Tax and L90A were
coprecipitated with p300, whereas K88A and V89A were defective for this
interaction (Fig. 5A). Comparable levels
of p300 in extracts prepared from transfected HeLa cells were verified
by immunoblotting (data not shown). In the transient cell death assay,
both the wild-type Tax and L90A mutant induced apoptosis, while the
cytotoxic effects of the mutants K88A and V89A were markedly reduced
(between 10 and 20% [Fig. 5B]). These findings were further
confirmed by the overall lack of nuclear fragmentation (pyknosis) in
HeLa cells expressing the K88A and V89A mutant proteins, as determined
by the absence of atypical DAPI-staining nuclei. By contrast, nuclear fragmentation was associated with wild-type Tax and L90A expression (Fig. 5C and D, arrows). We found that the K88A and V89A Tax mutants significantly transactivated the NF-
B-Luc reporter construct compared to NLS-
N81 and the wild-type Tax (Fig. 5E, right) but were
impaired in their abilities to activate CREB/ATF-dependent transcription from the viral LTR (Fig. 5E, left). Our data therefore suggest that direct binding of CBP/p300 significantly contributes to
the induction of apoptotic cell death by the HTLV-1 Tax.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 5.
(A) HeLa cells were transfected with RcCMV control
vector or the CMV-Tax (WT [wild type]), CMV-K88A, CMV-V89A, or
CMV-L90A expression construct. Coimmunoprecipitation (IP) was performed
using an anti-p300 antibody, and immunocomplexes containing Tax were
detected by immunoblotting using an anti-Tax monoclonal antibody.
Comparable levels of Tax expression for each mutant were confirmed by
Western blot analysis. (B) Tax-derived mutants K88A and V89A exhibited
markedly diminished apoptotic potentials in the transient cell death
assay compared to the wild-type Tax or L90A mutant. Results represent
average percentages derived from three independent experiments. (C)
Nuclear fragmentation induced by HTLV-1 Tax is correlated with
coactivator binding. HeLa cells were transfected with Tax-expressing
vectors and serum starved (0.5% FBS) for 24 h; Tax expression was
detected by immunofluorescence microscopy using an anti-Tax monoclonal
antibody. Nuclei were visualized by DAPI staining of DNA. Relative
average numbers of fragmented nuclei were quantified from three
nonoverlapping fields at an original magnification of ×400 from three
independent transfections. (D) Immunofluorescence detection of Tax and
Tax-derived mutants K88A, V89A, and L90A at an original magnification
of ×1,000 (arrows denote nuclear fragmentation bodies). (E)
Transactivation of HTLV-LTR-LUC and NF- B-Luc reporter constructs by
wild-type Tax, K88A, V89A, and NLS- N81 proteins in cotransfected
HeLa cells; the empty vector is shown as a control. Error bars
represent standard deviations.
|
|
Nucleus-directed expression of the CBP/p300-binding peptide of Tax
causes apoptosis.
To directly assess the death-inducing potential
of the coactivator-binding domain of Tax, amino acid residues 76 to 95 were expressed as an amino-terminal GFP fusion, localized to the
nucleus by incorporation of the SV40 large T-antigen-derived NLS
(NLS-Tax76-95-GFP). The CBP/p300-binding defective
mutation K88A was also expressed in the same context
(NLS-K88A76-95-GFP). As shown in Fig. 6A, the NLS-Tax76-95-GFP
expression construct was associated with significant cytotoxicity in
transient cell death assays versus the GFP vector control. Importantly,
the NLS-K88A76-95-GFP construct resulted in no detectable
apoptosis. We also observed that the NLS-Tax peptide-GFP
fusion-expressing construct appeared somewhat reduced in its cytotoxic
potential relative to the full-length wild-type Tax protein (data not
shown). This decrease could have resulted from protein folding effects
as a result of GFP sequences; alternatively, the absence of residues
required for Tax dimerization may alter cytotoxic effects
(53). The NLS-Tax76-95-GFP and
NLS-K88A76-95-GFP fusions were predominantly expressed in
the nuclei of transfected HeLa cells, as opposed to the generally diffuse expression pattern detected for the GFP control using quantitative, confocal fluorescence microscopy (Fig. 6B). Line quantification of relative fluorescence intensities confirmed that
GFP-Tax peptide fusions were expressed at comparable levels in
transfected cells (Fig. 6C). These data indicate that nuclear localization of the coactivator-binding peptide of Tax is responsible for the transactivator's death-inducing properties.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 6.
(A) Expression of the NLS-Tax76-95-GFP
fusion was associated with cytotoxicity in transient cell death assays;
the NLS-K88A76-95-GFP and GFP control plasmids did not
cause apoptosis. Results depict relative numbers of GFP-expressing
cells under serum deprivation conditions and are representative of
triplicate experiments. Error bars are indicative of standard
deviations. (B) GFP fusions were detected in transfected HeLa cells by
quantitative confocal microscopy as described in Materials and Methods.
The lines shown in the micrographs (B) indicate the regions of cells
quantified according to relative fluorescence intensities (C).
|
|
Ectopic expression of the p300 coactivator partially prevents
Tax-induced cell death.
Recent studies have demonstrated a
potential role for the p300 coactivator in apoptosis mediated by c-Fos,
the tumor suppressor p53, and
irradiation (43, 56, 61).
Consistent with a model whereby sequestration of the intranuclear
coactivator pool by Tax causes apoptosis, coexpression of CBP/p300
might be expected to inhibit the ability of Tax to promote cell death.
This hypothesis was tested by expressing a constant level of the
wild-type Tax protein in HeLa cells in the presence of increasing
concentrations of a CMV-driven p300 expression construct. Nuclear
fragmentation bodies induced by Tax expression, following 24 h of
serum deprivation, were visualized and quantified by DAPI staining and
by UV and fluorescence microscopy. The results indicated that
coexpression of p300 and Tax significantly reduced the induction of
apoptotic bodies or pyknosis in a dosage-dependent manner compared to
the vector control in absence of p300 (data not shown). In the
transient cell death assay, increased p300 expression, in the presence
of Tax, resulted in a dosage-dependent increase in the number of
-galactosidase-expressing cells (Fig.
7A and C). Exogenous p300 did not
significantly increase the number of
-galactosidase-positive cells
in the vector control experiment (CMV-lacZ), thus ruling out
the possibility that the observed increase in the number of blue cells
may have resulted from enhanced CMV promoter activation due to
increased p300 levels (Fig. 7A and C). Increases in p300 levels in
transfected HeLa cells were detected by Western blotting (Fig. 7B).
Ectopic p300 expression did not affect apoptosis induced by treatment
with the sphingolipid C2-ceramide (Fig. 7D), suggesting that both
p300-responsive and unresponsive pathways influence cell fate.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 7.
(A) Ectopic expression of p300 blocks Tax-induced
apoptosis in a dose-dependent manner. HeLa cells were transfected
either with an RcCMV control or CMV-Tax expression construct in the
presence of increasing concentrations of a CMV-p300 expression vector.
-Galactosidase-expressing cells were detected by staining with an
X-Gal solution. (B) Western blot analysis of increased p300-FLAG
expression in transfected HeLa cells using a monoclonal antibody
against human recombinant p300. (C) Average percentages of
Tax-associated cytotoxicity in the presence of increasing
concentrations of CMV-p300 were derived from transient cell death
assays performed in triplicate. (D) Increased p300 expression did not
affect apoptosis induced by C2-ceramide (Sigma) in transient cell death
assays; results are representative of duplicate experiments. Error bars
indicate standard deviations.
|
|
 |
DISCUSSION |
The HTLV-1 Tax has previously been shown by others to induce
programmed cell death in lymphoid and nonlymphoid cells through an
ill-defined mechanism (11, 12, 18, 28, 31, 36, 58). In this
respect, Tax resembles other cellular and viral oncogene products
(e.g., c-Myc, c-Jun, adenovirus E1A 12S protein, polyomavirus T
antigen, and human papillomavirus E7 protein) and certain regulators of
cellular proliferation (e.g., E2F, pRB, p53, and cyclin D) which also
possess apoptosis-inducing properties (1, 5, 8, 38, 39, 41,
57). Thus, by understanding the molecular mechanisms involved in
oncogene-associated cell death, we may gain further insight regarding
the identities of key genetic defects, preceding the establishment of
certain malignancies, which are required to support tumor survival.
Apoptosis induced by the HTLV-1 Tax was observed in HeLa clonal
populations that expressed the Tax-derived mutants M47 and NLS-
N81.
FACS analyses revealed the presence of distinct sub-G1 populations that were correlated with oligonucleosomal DNA
fragmentation, not observed in HeLa-N2 control cells. The relative
cytotoxic potentials for various Tax-derived mutants were determined
using a transient cell death assay. Interestingly, results from these experiments suggested that apoptotic cell death occurred only when
amino acid residues 81 to 108 of Tax were expressed in the nucleus. As
this domain encompasses the transcriptional coactivator-binding domain
of Tax (20, 21), two mutants defective for CBP/p300 binding
were assayed for their abilities to induce apoptosis and nuclear
fragmentation. The fact that mutations in Tax resulting in impairment
of p300 interactions severely hindered Tax-induced cell death is
suggestive that constitutive formation of Tax-CBP/p300 complexes might
perturb critical cell survival signals. Indeed, mutually exclusive
occupancy of these coactivators by nuclear hormone receptors is
believed to play an important role in the potent apoptosis-inducing
properties of retinoid and glucocorticoid, anticancer therapeutic
compounds (9, 10, 22, 26). Nuclear expression of the
coactivator-binding peptide spanning residues 76 to 95 of Tax as a GFP
fusion caused significant cell death and nuclear fragmentation in
transient assays. Its counterpart, containing the K88A mutation, did
not induce apoptosis. In support of a role for CBP/p300 in mediating
apoptotic responses, ectopic expression of the p300 coactivator
prevented Tax-induced programmed cell death in a dosage-dependent
manner. These results suggest that the HTLV-1 transactivator might
promote caspase activation and apoptosis, either through direct
coactivator interactions or by inducing numerous nuclear factors to
collectively overwhelm the cellular transcriptional machinery.
Alternatively, an unknown protein(s) might interact with residues found
within the coactivator binding domain of Tax to induce cell death;
overexpression of p300 could then competitively displace such factors.
Rel/NF-
B family members have been shown to play essential roles in
modulating apoptotic pathways (2, 3). Whether NF-
B promotes apoptosis, or acts in a protective manner, appears dependent on the nature of stimulation, the identity of Rel-related subunits activated, and the duration of the stimulating signal (2,
3). In contrast to tumor necrosis factor alpha, IL-1, and
lipopolysaccharides that trigger transient NF-
B activation, Tax
expression is known to result in prolonged induction of
NF-
B-dependent transcription through the targeted activation of
I
B-kinase complex components and constitutive phosphorylation or
degradation of I
B
and I
B
(50). The aberrant,
persistent activation of NF-
B transcription by Tax could exert a
proapoptotic function (28). Indeed, long-term expression of
Tax, in either Jurkat or rat fibroblast (5R)-derived cell lines, has
led to the selection of clones that can no longer respond to
NF-
B-inducing signals (47, 59). Consistent with these
findings, our results underscore the importance of Tax-mediated NF-
B
responses for the induction of apoptosis under conditions of cellular
stress. Tax mutants defective in NF-
B activation exhibited reduced
apoptosis-inducing activities and inhibition of Tax-mediated NF-
B
transactivation partially inhibited cell death. Rel/NF-
B subunits
utilize CBP/p300 in a phosphorylation-dependent manner and stimulate
the expression of numerous other factors that also require the
recruitment of coactivators for their transcription functions. It is
tempting to speculate that persistent, Tax-mediated NF-
B
transactivation could indirectly increase the demands for CBP/p300
through cascade effects; and in cells in which these demands are not
adequately satisfied, uncoupled signaling pathways lead to cellular death.
A striking feature of HTLV-1-infected lymphocytes in vivo is the
absence of detectable viral gene expression. Thus, in response to
T-cell activation, increases in Tax protein levels within
subpopulations of HTLV-1-infected cells may be accompanied by a burst
of viral expression, followed by immediate apoptotic cell death and/or clearance by immune responses. Selective pressures for the maintenance of reduced Tax expression, therefore, potentially may contribute to
viral latency, allowing infected cells to evade host immune surveillance mechanisms. The late onset of many cancers, including acute or lymphoma-stage ATLL, is thought to result from a genetic, selective process whereby a clonal neoplastic cell population that
avoids or bypasses apoptotic cell death is the cause of neoplasia. The
data presented here indicate that direct and/or indirect titration of
the transcriptional coactivator p300 by the HTLV-1 Tax results in
apoptosis, raising the intriguing possibility that limiting concentrations of nuclear CBP/p300 may pose an early barrier to oncogenic transformation.
 |
ACKNOWLEDGMENTS |
This work was supported by G. Franchini (Basic Research
Laboratory, Division of Basic Sciences, National Cancer Institute, National Institutes of Health) and in part by C. Z. Giam (Department of
Microbiology and Immunology, Uniformed Services University of the
Health Sciences; grants RO1 CA48709 and RO1 CA/GM 75688).
We acknowledge James McNally and Tatiana Karpova, Laboratory of
Receptor Biology and Gene Expression (LRBGE), Fluorescence Imaging
Facility, National Cancer Institute, NIH, for use of the Leica TCS
confocal fluorescence microscope and quantitation software. Jeremy
Hansen is thanked for technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Basic Research
Laboratory, Division of Basic Sciences, National Cancer Institute,
National Institutes of Health, Building 41, Room D804, 9000 Rockville
Pike, Bethesda, MD 20892. Phone: (301) 402-0303. Fax: (301) 402-0055. E-mail: cbeben{at}helix.nih.gov.
 |
REFERENCES |
| 1.
|
Allemand, I.,
G. Grimber,
M. Kornprobst,
M. Bennoun,
T. Molina,
P. Briand, and V. Joulin.
1995.
Compensatory apoptosis in response to SV40 large T antigen expression in the liver.
Oncogene
11:2583-2590[Medline].
|
| 2.
|
Baichwal, V. R., and P. A. Baeuerle.
1997.
Activate NF-kappa B or die?
Curr. Biol.
7:R94-R96[CrossRef][Medline].
|
| 3.
|
Barkett, M., and T. D. Gilmore.
1999.
Control of apoptosis by Rel/NF-kappaB transcription factors.
Oncogene
18:6910-6924[CrossRef][Medline].
|
| 4.
|
Bex, F.,
M. J. Yin,
A. Burny, and R. B. Gaynor.
1998.
Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB-binding protein and p300.
Mol. Cell. Biol.
18:2392-2405[Abstract/Free Full Text].
|
| 5.
|
Blagosklonny, M. V.
1999.
A node between proliferation, apoptosis, and growth arrest.
Bioessays
21:704-709[CrossRef][Medline].
|
| 6.
|
Borrow, J.,
V. P. Stanton,
M. Andresen,
R. Becher,
F. G. Behm,
R. S. K. Chaganti,
C. I. Civin,
C. Disteche,
I. Dube,
A. M. Frischauf,
D. Horsman,
F. Mitelman,
S. Volinia,
A. E. Watmore, and D. E. Housman.
1996.
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.
Nat. Genet.
14:33-41[CrossRef][Medline].
|
| 7.
|
Bossy-Wetzel, E.,
L. Bakiri, and M. Yaniv.
1997.
Induction of apoptosis by the transcription factor c-Jun.
EMBO J.
16:1695-1709[CrossRef][Medline].
|
| 8.
|
Burns, T. F., and W. S. El-Deiry.
1999.
The p53 pathway and apoptosis.
J. Cell Physiol.
181:231-239[CrossRef][Medline].
|
| 9.
|
Caelles, C.,
J. M. Gonzales-Sancho, and A. Munoz.
1997.
Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway.
Genes Dev.
11:3351-3364[Abstract/Free Full Text].
|
| 10.
|
Chakravarti, D.,
V. J. LaMorte,
M. C. Nelson,
T. Nakajima,
I. G. Schulman,
H. Juguilon,
M. Montminy, and R. M. Evans.
1996.
Role of CBP/p300 in nuclear receptor signaling.
Nature
383:99-103[CrossRef][Medline].
|
| 11.
|
Chlichlia, K.,
G. Moldenhauer,
P. T. Daniel,
M. Busslinger,
L. Gazzolo,
V. Schirrmacher, and K. Khazaie.
1995.
Immediate effects of reversible HTLV-I Tax function: T-cell activation and apoptosis.
Oncogene
10:269-277[Medline].
|
| 12.
|
Chlichia, K.,
M. Busslinger,
M. E. Peter,
H. Walczak,
P. H. Krammer,
V. Schirrmacher, and K. Khazaie.
1997.
ICE-proteases mediate HTLV-I Tax-induced apoptotic T-cell death.
Oncogene
14:2265-2272[CrossRef][Medline].
|
| 13.
|
Colgin, M. A., and J. K. Nyborg.
1998.
The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein.
J. Virol.
72:9396-9399[Abstract/Free Full Text].
|
| 14.
|
Eckner, R.,
M. E. Ewen,
D. Newsome,
M. Gerdes,
J. A. DeCaprio,
J. B. Lawrence, and D. M. Livingston.
1994.
Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.
Genes Dev.
8:869-884[Abstract/Free Full Text].
|
| 15.
|
Gessain, A.,
F. Barin,
J. C. Vernant,
O. Gout,
L. Maurs,
A. Calander, and G. de The.
1985.
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.
Lancet
ii:407-410.
|
| 16.
|
Giebler, H. A.,
J. E. Loring,
K. Van Orden,
M. A. Colgin,
J. E. Garrus,
K. Escudero,
A. Brauweiler, and J. K. Nyborg.
1997.
Anchoring of CREB-binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation.
Mol. Cell. Biol.
17:5156-5164[Abstract].
|
| 17.
|
Giles, R. H.,
D. J. Peters, and M. H. Breuning.
1998.
Conjunction dysfunction: CBP/p300 in human disease.
Trends Genet.
14:178-183[CrossRef][Medline].
|
| 18.
|
Hall, A. P.,
J. Irvine,
K. Blyth,
E. R. Cameron,
D. E. Onions, and M. E. Campbell.
1998.
Tumors derived from HTLV-I Tax transgenic mice are characterized by enhanced levels of apoptosis and oncogene expression.
J. Pathol.
186:209-214[CrossRef][Medline].
|
| 19.
|
Harrington, E. A.,
M. R. Bennett,
A. Fanidi, and G. I. Evan.
1994.
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
EMBO J.
13:3286-3295[Medline].
|
| 20.
|
Harrod, R.,
Y. L. Kuo,
Y. Tang,
Y. Yao,
A. Vassilev,
Y. Nakatani, and C. Z. Giam.
2000.
p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex.
J. Biol. Chem.
275:11852-11857[Abstract/Free Full Text].
|
| 21.
|
Harrod, R.,
Y. Tang,
C. Nicot,
H. S. Lu,
A. Vassilev,
Y. Nakatani, and C. Z. Giam.
1998.
An exposed KID-like domain in human T-cell lymphotropic virus type-1 Tax is responsible for the recruitment of coactivators CBP/p300.
Mol. Cell. Biol.
18:5052-5061[Abstract/Free Full Text].
|
| 22.
|
Helmberg, A.,
N. Auphan,
C. Caelles, and M. Karin.
1995.
Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor.
EMBO J.
14:452-460[Medline].
|
| 23.
|
Horvai, A. E.,
L. Xu,
E. Korzus,
G. Brard,
D. Kalafus,
T. M. Mullen,
D. W. Rose,
M. G. Rosenfeld, and C. K. Glass.
1997.
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300.
Proc. Natl. Acad. Sci. USA
94:1074-1079[Abstract/Free Full Text].
|
| 24.
|
Janknecht, R., and T. Hunter.
1999.
Nuclear fusion of signaling pathways.
Science
284:443-444[Free Full Text].
|
| 25.
|
Kamei, Y.,
L. Xu,
T. Heinzel,
J. Torchia,
R. Kurokawa,
B. Gloss,
S. C. Lin,
R. A. Heyman,
D. W. Rose,
C. K. Glass, and M. G. Rosenfeld.
1996.
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.
Cell
85:403-414[CrossRef][Medline].
|
| 26.
|
Kawasaki, H.,
R. Eckner,
T. P. Yao,
K. Taira,
R. Chiu,
D. M. Livingston, and K. K. Yokoyama.
1998.
Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation.
Nature
393:284-289[CrossRef][Medline].
|
| 27.
|
Kwok, R. P.,
M. E. Laurance,
J. R. Lundblad,
P. S. Goldman,
H. Shih,
L. M. Connor,
S. J. Marriott, and R. H. Goodman.
1996.
Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP.
Nature
380:642-646[CrossRef][Medline].
|
| 28.
|
Los, M.,
K. Khazaie,
K. Schulze-Osthoff,
P. A. Baeuerle,
V. Schirrmacher, and K. Chlichlia.
1998.
Human T cell leukemia virus-I (HTLV-I) Tax-mediated apoptosis in activated T cells requires an enhanced intracellular prooxidant state.
J. Immunol.
161:3050-3055[Abstract/Free Full Text].
|
| 29.
|
Maestro, R.,
A. P. Dei Tos,
Y. Hamamori,
S. Krasnokutsky,
V. Sartorelli,
L. Kedes,
C. Doglioni,
D. H. Beach, and G. J. Hannon.
1999.
Twist is a potential oncogene that inhibits apoptosis.
Genes Dev.
13:2207-2217[Abstract/Free Full Text].
|
| 30.
|
Miura, M.,
H. Zhu,
R. Rotello,
E. A. Hartwieg, and J. Yuan.
1993.
Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C.elegans cell death gene ced-3.
Cell
75:653-660[CrossRef][Medline].
|
| 31.
|
Nicot, C.,
T. Astier-Gin, and B. Guillemain.
1997.
Activation of Bcl2 expression in human endothelial cells chronically expressing the human T-cell lymphotropic virus type-I.
Virology
236:47-53[CrossRef][Medline].
|
| 32.
|
Nicot, C.,
R. Mahieux,
R. Opavsky,
A. Cereseto,
L. Wolff,
J. N. Brady, and G. Franchini.
2000.
HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.
Oncogene
19:2155-2164[CrossRef][Medline].
|
| 33.
|
Nicot, C.,
R. Mahieux,
S. Takemoto, and G. Franchini.
2000.
Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples.
Blood
96:275-281[Abstract/Free Full Text].
|
| 34.
|
Nicot, C.,
F. Tie, and G. Z. Giam.
1998.
Cytoplasmic forms of human T-cell leukemia virus type 1 Tax induce NF- B activation.
J. Virol.
72:6777-6784[Abstract/Free Full Text].
|
| 35.
|
Nicot, C.,
T. Astier-Gin,
E. Edouard,
E. Legrand,
D. Moynet,
A. Vital,
D. Londos-Gagliardi,
J. P. Moreau, and B. Guillemain.
1993.
Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles.
Virus Res.
30:317-333[CrossRef][Medline].
|
| 36.
|
Ohya, O.,
U. Tomaru,
I. Yamashita,
T. Kasai,
K. Morita,
H. Ikeda,
A. Wakisaka, and T. Yoshiki.
1997.
HTLV-I induced myeloneuropathy in WKAH rats: apoptosis and local activation of the HTLV-I pX and TNF-alpha genes implicated in the pathogenesis.
Leukemia
11:255-257.
|
| 37.
|
Osame, M.,
K. Usuku,
S. Izumo,
N. Ljichi,
H. Amitani,
A. Igata,
M. Matsumoto, and M. Tara.
1986.
HTLV-I associated myelopathy, a new clinical entity.
Lancet
i:1031-1032.
|
| 38.
|
Pan, H., and A. E. Griep.
1994.
Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
Genes Dev.
8:1285-1299[Abstract/Free Full Text].
|
| 39.
|
Pandey, S., and E. Wang.
1995.
Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse.
J. Cell. Biochem.
58:135-150[CrossRef][Medline].
|
| 40.
|
Petrij, F.,
R. H. Giles,
H. G. Dauwerse,
J. J. Saris,
R. C. Hennekam,
M. Masuno,
N. Tommerup,
G. J. van Ommen,
R. H. Goodman, and D. J. Peters.
1995.
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.
Nature
376:348-351[CrossRef][Medline].
|
| 41.
|
Pierce, A. M.,
R. Scheinder-Broussard,
I. B. Gimenez-Conti,
J. L. Russel,
C. J. Conti, and D. G. Johnson.
1999.
E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model.
Mol. Cell. Biol.
19:6408-6414[Abstract/Free Full Text].
|
| 42.
|
Poiesz, B. J.,
F. W. Ruscetti,
A. F. Gazdar,
P. A. Bunn,
J. D. Minna, and R. C. Gallo.
1980.
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.
Proc. Natl. Acad. Sci. USA
77:7415-7419[Abstract/Free Full Text].
|
| 43.
|
Preston, G. A.,
D. Srinivasan, and J. C. Barrett.
2000.
Apoptotic response to growth factor deprivation involves cooperative interactions between c-Fos and p300.
Cell. Death Differ.
7:215-226[CrossRef][Medline].
|
| 44.
|
Ravi, R.,
B. Mookerjee,
Y. van Hensbergen,
G. C. Bedi,
A. Giordano,
W. S. El-Deiry,
E. J. Fuchs, and A. Bedi.
1998.
p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300.
Cancer Res.
58:4531-4536[Abstract/Free Full Text].
|
| 45.
|
Reed, J. C.
1998.
Dysregulation of apoptosis in cancer.
Cancer J. Sci. Am.
4:S8-S14.
|
| 46.
|
Reed, J. C.
1999.
Mechanisms of apoptosis avoidance in cancer.
Curr. Opin. Oncol.
11:68-75[CrossRef][Medline].
|
| 47.
|
Ruben, S. M., and C. A. Rosen.
1990.
Suppression of signals required for activation of transcription factor NF-kappa B in cells constitutively expressing the HTLV-I Tax protein.
New Biol.
2:894-902[Medline].
|
| 48.
|
Sheppard, K. A.,
K. M. Phelps,
A. J. Williams,
D. Thanos,
C. K. Glass,
M. G. Rosenfeld,
M. E. Gerritsen, and T. Collins.
1998.
Transcriptional activation by NF-kappaB requires multiple coactivators.
J. Biol. Chem.
273:29291-29294[Abstract/Free Full Text].
|
| 49.
|
Smith, M. R., and W. C. Greene.
1990.
Identification of HTLV-I Tax trans-activator mutants exhibiting novel transcriptional phenotypes.
Genes Dev.
4:1875-1885[Abstract/Free Full Text].
|
| 50.
|
Sun, S. C., and D. W. Ballard.
1999.
Persistent activation of NF-kappaB by the Tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases.
Oncogene
18:6948-6958[CrossRef][Medline].
|
| 51.
|
Suzuki, T.,
M. Uchida-Toita, and M. Yoshida.
1999.
Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
Oncogene
18:4137-4143[CrossRef][Medline].
|
| 52.
|
Thompson, C. B.
1995.
Apoptosis in the pathogenesis and treatment of disease.
Science
267:1456-1462[Abstract/Free Full Text].
|
| 53.
|
Tie, F.,
N. Adya,
W. C. Greene, and C. Z. Giam.
1996.
Interaction of the human T-lymphotropic virus type 1 Tax dimer with CREB and the viral 21-base-pair repeat.
J. Virol.
70:8368-8374[Abstract].
|
| 54.
|
Van Orden, K.,
J.-P. Yan,
A. Ulloa, and J. K. Nyborg.
1999.
Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control.
Oncogene
18:3766-3772[CrossRef][Medline].
|
| 55.
|
Van Orden, K.,
H. A. Giebler,
I. Lemasson,
M. Gonzales, and J. K. Nyborg.
1999.
Binding of p53 to the KIX domain of CREB binding protein.
J. Biol. Chem.
274:26321-26328[Abstract/Free Full Text].
|
| 56.
|
Webster, G. A., and N. D. Perkins.
1999.
Transcriptional cross talk between NF- B and p53.
Mol. Cell. Biol.
19:3485-3495[Abstract/Free Full Text].
|
| 57.
|
White, E.,
P. Sabbatini,
M. Debbas,
W. S. Wold,
D. I. Kuscher, and L. R. Gooding.
1992.
The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha.
Mol. Cell. Biol.
12:2570-2580[Abstract/Free Full Text].
|
| 58.
|
Yamada, T.,
S. Yamaoka,
T. Goto,
M. Nakai,
M. Tsujimoto, and M. Hatanaka.
1994.
The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein.
J. Virol.
68:3374-3379[Abstract/Free Full Text].
|
| 59.
|
Yamaoka, S.,
G. Courtois,
C. Bessia,
S. T. Whiteside,
R. Weil,
F. Agou,
H. E. Kirk,
R. J. Kay, and A. Israel.
1998.
Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation.
Cell
93:1231-1240[CrossRef][Medline].
|
| 60.
|
Yao, T. P.,
S. P. Oh,
M. Fuchs,
N. D. Zhou,
L. E. Ch'ng,
D. Newsome,
R. T. Bronson,
E. Li,
D. M. Livingston, and R. Eckner.
1998.
Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.
Cell
93:361-372[CrossRef][Medline].
|
| 61.
|
Yuan, Z. M.,
Y. Huang,
T. Ishiko,
S. Nakada,
T. Utsugisawa,
H. Shioya,
Y. Utsugisawa,
Y. Shi,
R. Weichselbaum, and D. Kufe.
1999.
Function for p300 and not CBP in the apoptotic response to DNA damage.
Oncogene
18:5714-5717[CrossRef][Medline].
|
Molecular and Cellular Biology, November 2000, p. 8580-8589, Vol. 20, No. 22
0270-7306/00/$04.00+0
This article has been cited by other articles:
-
Fukuda, R.-i., Tsuchiya, K., Suzuki, K., Itoh, K., Fujita, J., Utsunomiya, A., Tsuji, T.
(2009). Human T-cell Leukemia Virus Type I Tax Down-regulates the Expression of Phosphatidylinositol 3,4,5-Trisphosphate Inositol Phosphatases via the NF-{kappa}B Pathway. J. Biol. Chem.
284: 2680-2689
[Abstract]
[Full Text]
-
Hishiki, T., Ohshima, T., Ego, T., Shimotohno, K.
(2007). BCL3 Acts as a Negative Regulator of Transcription from the Human T-cell Leukemia Virus Type 1 Long Terminal Repeat through Interactions with TORC3. J. Biol. Chem.
282: 28335-28343
[Abstract]
[Full Text]
-
Krueger, A., Fas, S. C., Giaisi, M., Bleumink, M., Merling, A., Stumpf, C., Baumann, S., Holtkotte, D., Bosch, V., Krammer, P. H., Li-Weber, M.
(2006). HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood
107: 3933-3939
[Abstract]
[Full Text]
-
Awasthi, S., Sharma, A., Wong, K., Zhang, J., Matlock, E. F., Rogers, L., Motloch, P., Takemoto, S., Taguchi, H., Cole, M. D., Luscher, B., Dittrich, O., Tagami, H., Nakatani, Y., McGee, M., Girard, A.-M., Gaughan, L., Robson, C. N., Monnat, R. J. Jr., Harrod, R.
(2005). A Human T-Cell Lymphotropic Virus Type 1 Enhancer of Myc Transforming Potential Stabilizes Myc-TIP60 Transcriptional Interactions. Mol. Cell. Biol.
25: 6178-6198
[Abstract]
[Full Text]
-
Sieburg, M., Tripp, A., Ma, J.-W., Feuer, G.
(2004). Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 Tax Oncoproteins Modulate Cell Cycle Progression and Apoptosis. J. Virol.
78: 10399-10409
[Abstract]
[Full Text]
-
Vasudevan, K. M., Gurumurthy, S., Rangnekar, V. M.
(2004). Suppression of PTEN Expression by NF-{kappa}B Prevents Apoptosis. Mol. Cell. Biol.
24: 1007-1021
[Abstract]
[Full Text]
-
Tripp, A., Liu, Y., Sieburg, M., Montalbano, J., Wrzesinski, S., Feuer, G.
(2003). Human T-Cell Leukemia Virus Type 1 Tax Oncoprotein Suppression of Multilineage Hematopoiesis of CD34+ Cells In Vitro. J. Virol.
77: 12152-12164
[Abstract]
[Full Text]
-
Kawata, S., Ariumi, Y., Shimotohno, K.
(2003). p21Waf1/Cip1/Sdi1 Prevents Apoptosis as Well as Stimulates Growth in Cells Transformed or Immortalized by Human T-Cell Leukemia Virus Type 1-Encoded Tax. J. Virol.
77: 7291-7299
[Abstract]
[Full Text]
-
Harrod, R., Nacsa, J., Van Lint, C., Hansen, J., Karpova, T., McNally, J., Franchini, G.
(2003). Human Immunodeficiency Virus Type-1 Tat/Co-activator Acetyltransferase Interactions Inhibit p53Lys-320 Acetylation and p53-responsive Transcription. J. Biol. Chem.
278: 12310-12318
[Abstract]
[Full Text]
-
Mahieux, R., Pise-Masison, C., Gessain, A., Brady, John. N., Olivier, R., Perret, E., Misteli, T., Nicot, C.
(2001). Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage. Blood
98: 3762-3769
[Abstract]
[Full Text]
-
Nicot, C., Mahieux, R., Pise-Masison, C., Brady, J., Gessain, A., Yamaoka, S., Franchini, G.
(2001). Human T-Cell Lymphotropic Virus Type 1 Tax Represses c-Myb-Dependent Transcription through Activation of the NF-{kappa}B Pathway and Modulation of Coactivator Usage. Mol. Cell. Biol.
21: 7391-7402
[Abstract]
[Full Text]
-
Cho, S., Tian, Y., Benjamin, T. L.
(2001). Binding of p300/CBP Co-activators by Polyoma Large T Antigen. J. Biol. Chem.
276: 33533-33539
[Abstract]
[Full Text]